1. Home
  2. INTZ vs COCP Comparison

INTZ vs COCP Comparison

Compare INTZ & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$1.03

Market Cap

18.9M

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.05

Market Cap

15.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTZ
COCP
Founded
1983
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
15.3M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
INTZ
COCP
Price
$1.03
$1.05
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.25
$6.00
AVG Volume (30 Days)
140.8K
55.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
85.78
8.02
EPS
N/A
N/A
Revenue
$5,771,000.00
$12,712,091.00
Revenue This Year
$35.44
N/A
Revenue Next Year
$23.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$0.75
$0.86
52 Week High
$2.64
$2.19

Technical Indicators

Market Signals
Indicator
INTZ
COCP
Relative Strength Index (RSI) 49.43 57.64
Support Level $0.86 $1.01
Resistance Level $1.12 $1.10
Average True Range (ATR) 0.10 0.07
MACD 0.03 0.01
Stochastic Oscillator 61.28 73.81

Price Performance

Historical Comparison
INTZ
COCP

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: